343 related articles for article (PubMed ID: 8573565)
1. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
2. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W
Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031
[TBL] [Abstract][Full Text] [Related]
3. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.
Cogoi S; Ballico M; Bonora GM; Xodo LE
Cancer Gene Ther; 2004 Jul; 11(7):465-76. PubMed ID: 15118760
[TBL] [Abstract][Full Text] [Related]
5. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
Cogoi S; Quadrifoglio F; Xodo LE
Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
Mayfield C; Squibb M; Miller D
Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
[TBL] [Abstract][Full Text] [Related]
7. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
8. Distamycin A complexation with a nucleic acid triple helix.
Durand M; Maurizot JC
Biochemistry; 1996 Jul; 35(28):9133-9. PubMed ID: 8703918
[TBL] [Abstract][Full Text] [Related]
9. The effects of local DNA sequence on the interaction of ligands with their preferred binding sites.
Hampshire AJ; Fox KR
Biochimie; 2008 Jul; 90(7):988-98. PubMed ID: 18226601
[TBL] [Abstract][Full Text] [Related]
10. Minor groove binding ligands alter the rotational positioning of DNA fragments on nucleosome core particles.
Brown PM; Fox KR
J Mol Biol; 1996 Oct; 262(5):671-85. PubMed ID: 8876646
[TBL] [Abstract][Full Text] [Related]
11. Presence of divalent cation is not mandatory for the formation of intramolecular purine-motif triplex containing human c-jun protooncogene target.
Kaushik S; Kaushik M; Svinarchuk F; Malvy C; Fermandjian S; Kukreti S
Biochemistry; 2011 May; 50(19):4132-42. PubMed ID: 21381700
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of triple helical DNA by a benzopyridoquinoxaline intercalator.
Marchand C; Bailly C; Nguyen CH; Bisagni E; Garestier T; Hélène C; Waring MJ
Biochemistry; 1996 Apr; 35(15):5022-32. PubMed ID: 8664295
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
14. Berenil complexation with a nucleic acid triple helix.
Durand M; Thuong NT; Maurizot JC
J Biomol Struct Dyn; 1994 Jun; 11(6):1191-202. PubMed ID: 7946069
[TBL] [Abstract][Full Text] [Related]
15. Interactions of cytosine derivatives with T.A interruptions in pyrimidine.purine.pyrimidine DNA triplexes.
Verma S; Miller PS
Bioconjug Chem; 1996; 7(5):600-5. PubMed ID: 8889023
[TBL] [Abstract][Full Text] [Related]
16. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein.
Chen S; Supakar PC; Vellanoweth RL; Song CS; Chatterjee B; Roy AK
Mol Endocrinol; 1997 Jan; 11(1):3-15. PubMed ID: 8994183
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
18. Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides.
Perrouault L; Asseline U; Rivalle C; Thuong NT; Bisagni E; Giovannangeli C; Le Doan T; Hélène C
Nature; 1990 Mar; 344(6264):358-60. PubMed ID: 2156170
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the calicheamicin gamma 1I-DNA complex.
Kumar RA; Ikemoto N; Patel DJ
J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
[TBL] [Abstract][Full Text] [Related]
20. Footprinting studies of sequence recognition by mithramycin.
Cons BM; Fox KR
Anticancer Drug Des; 1990 Feb; 5(1):93-7. PubMed ID: 2156518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
